Neurology Devices Market Revenue, Growth Rate, Customer Needs, Trend, Manufacturers and Forecast to 2025 – Express Journal

Latest research with COVID-19 impact analysis of Global Neurology Devices Industry 2025 Situations, Growth, Prospects, & Sales Market is analyzed. The deep-dive analysis of Neurology Devices market development factors, risks & market maturity analysis is conducted. The research study is segmented based on top product types, applications, companies, & end-users. The Neurology Devices industry share & size analysis is conducted. The forecast strategies, Neurology Devices business plans, changing dynamics & policies are studied comprehensively. The crucial opportunities to focus on, market driving forces & statistics are evaluated.

The research report on Neurology Devices market offers a complete assessment of this business landscape while highlighting the production as well as the consumption aspects. Factors including growth drivers, limitations, and opportunities impacting the market dynamics are also specified in the document. A detailed five Porters analysis of each company operating in this industry is conducted to conclude emerging prospects.

The study specifies the major business strategies which offer a robust profit potential. However, the advent of COVID-19 outbreak may have major modifications in the expansion of the overall market. Thus, the report assesses and provides detailed assessment of the impact of COVID-19 pandemic on the market remuneration.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/230462

Major parameters specified in the table of contents:

Additional takeaways from the Neurology Devices market report:

Neurology Devices research provides answers to the following key questions:

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/230462

Link:
Neurology Devices Market Revenue, Growth Rate, Customer Needs, Trend, Manufacturers and Forecast to 2025 - Express Journal

What We Know So Far about How COVID Affects the Nervous System – Scientific American

Many of the symptoms experienced by people infected with SARS-CoV-2 involve the nervous system. Patients complain of headaches, muscle and joint pain, fatigue and brain fog, or loss of taste and smellall of which can last from weeks to months after infection. In severe cases, COVID-19 can also lead to encephalitis or stroke. The virus has undeniable neurological effects. But the way it actually affects nerve cells still remains a bit of a mystery. Can immune system activation alone produce symptoms? Or does the novel coronavirus directly attack the nervous system?

Some studiesincluding a recent preprint paper examining mouse and human brain tissueshow evidence that SARS-CoV-2 can get into nerve cells and the brain. The question remains as to whether it does so routinely or only in the most severe cases. Once the immune system kicks into overdrive, the effects can be far-ranging, even leading immune cells to invade the brain, where they can wreak havoc.

Some neurological symptoms are far less serious yet seem, if anything, more perplexing. One symptomor set of symptomsthat illustrates this puzzle and has gained increasing attention is an imprecise diagnosis called brain fog. Even after their main symptoms have abated, it is not uncommon for COVID-19 patients to experience memory loss, confusion and other mental fuzziness. What underlies these experiences is still unclear, although they may also stem from the body-wide inflammation that can go along with COVID-19. Many people, however, develop fatigue and brain fog that lasts for months even after a mild case that does not spur the immune system to rage out of control.

Another widespread symptom called anosmia, or loss of smell, might also originate from changes that happen without nerves themselves getting infected. Olfactory neurons, the cells that transmit odors to the brain, lack the primary docking site, or receptor, for SARS-CoV-2, and they do not seem to get infected. Researchers are still investigating how loss of smell might result from an interaction between the virus and another receptor on the olfactory neurons or from its contact with nonnerve cells that line the nose.

Experts say the virus need not make it inside neurons to cause some of the mysterious neurological symptoms now emerging from the disease. Many pain-related effects could arise from an attack on sensory neurons, the nerves that extend from the spinal cord throughout the body to gather information from the external environment or internal bodily processes. Researchers are now making headway in understanding how SARS-CoV-2 could hijack pain-sensing neurons, called nociceptors, to produce some of COVID-19s hallmark symptoms.

Neuroscientist Theodore Price, who studies pain at the University of Texas at Dallas, took note of the symptoms reported in the early literature and cited by patients of his wife, a nurse practitioner who sees people with COVID remotely. Those symptoms include sore throat, headaches, body-wide muscle pain and severe cough. (The cough is triggered in part by sensory nerve cells in the lungs.)

Curiously, some patients report a loss of a particular sensation called chemethesis, which leaves them unable to detect hot chilies or cool peppermintsperceptions conveyed by nociceptors, not taste cells. While many of these effects are typical of viral infections, the prevalence and persistence of these pain-related symptomsand their presence in even mild cases of COVID-19suggest that sensory neurons might be affected beyond normal inflammatory responses to infection. That means the effects may be directly tied to the virus itself. Its just striking, Price says. The affected patients all have headaches, and some of them seem to have pain problems that sound like neuropathies, chronic pain that arises from nerve damage. That observation led him to investigate whether the novel coronavirus could infect nociceptors.

The main criteria scientists use to determine whether SARS-CoV-2 can infect cells throughout the body is the presence of angiotensin-converting enzyme 2 (ACE2), a protein embedded in the surface of cells. ACE2 acts as a receptor that sends signals into the cell to regulate blood pressure and is also an entry point for SARS-CoV-2. So Price went looking for it in human neurons in a study now published in the journal PAIN.

Nociceptorsand other sensory neuronslive in discreet clusters, found just outside the spinal cord, called dorsal root ganglia (DRG). Price and his team procured nerve cells donated after death or cancer surgeries. The researchers performed RNA sequencing, a technique to determine which proteins a cell is about to produce, and they used antibodies to target ACE2 itself. They found that a subset of DRG neurons did contain ACE2, providing the virus a portal into the cells.

Sensory neurons send out long tendrils called axons, whose endings sense specific stimuli in the body and then transmit them to the brain in the form of electrochemical signals. The particular DRG neurons that contained ACE2 also had the genetic instructions, the mRNA, for a sensory protein called MRGPRD. That protein marks the cells as a subset of neurons whose endings are concentrated at the bodys surfacesthe skin and inner organs, including the lungswhere they would be poised to pick up the virus.

Price says nerve infection could contribute to acute, as well as lasting, symptoms of COVID. The most likely scenario would be that the autonomic and sensory nerves are affected by the virus, he says. We know that if sensory neurons get infected with a virus, it can have long-term consequences, even if the virus does not stay in cells.

But, Price adds, it does not need to be that the neurons get infected. In another recent study, he compared genetic sequencing data from lung cells of COVID patients and healthy controls and looked for interactions with healthy human DRG neurons. Price says his team found a lot of immune-system-signaling molecules called cytokines from the infected patients that could interact with receptors on neurons. Its basically a bunch of stuff we know is involved in neuropathic pain. That observation suggests that nerves could be undergoing lasting damage from the immune molecules without being directly infected by the virus.

Anne Louise Oaklander, a neurologist at Massachusetts General Hospital, who wrote a commentary accompanying Prices paper in PAIN, says that the study was exceptionally good, in part because it used human cells. But, she adds, we dont have evidence that direct entry of the virus into [nerve] cells is the major mechanism of cellular [nerve] damage, though the new findings do not discount that possibility. It is absolutely possible that inflammatory conditions outside nerve cells could alter their activity or even cause permanent damage, Oaklander says. Another prospect is that viral particles interacting with neurons could lead to an autoimmune attack on nerves.

ACE2 is widely thought to be the novel coronaviruss primary entry point. But Rajesh Khanna, a neuroscientist and pain researcher at the University of Arizona, observes that ACE2 is not the only game in town for SARS-CoV-2 to come into cells. Another protein, called neuropilin-1 (NRP1), could be an alternate doorway for viral entry, he adds. NRP1 plays an important role in angiogenesis (the formation of new blood vessels) and in growing neurons long axons.

That idea came from studies in cells and in mice. It was found that NRP1 interacts with the viruss infamous spike protein, which it uses to gain entry into cells. We proved that it binds neuropilin and that the receptor has infectious potential, says virologist Giuseppe Balistreri of the University of Helsinki, who co-authored the mouse study, which was published in Sciencealong with a separate study in cells. It appears more likely that NRP1 acts as a co-factor with ACE2 than that the protein alone affords the virus entry to cells. What we know is that when we have the two receptors, we get more infection. Together, its much more powerful, Balistreri adds.

Those findings piqued the interest of Khanna, who was studying vascular endothelial growth factor (VEGF), a molecule with a long-recognized role in pain signaling that also binds to NRP1. He wondered whether the virus would affect pain signaling through NRP1, so he tested it in rats in a study that was also published in PAIN. We put VEGF in the animal [in the paw], and lo and behold, we saw robust pain over the course of 24 hours, Khanna says. Then came the really cool experiment: We put in VEGF and spike at the same time, and guess what? The pain is gone.

The study showed what happens to the neurons signaling when the virus tickles the NRP1 receptor, Balistreri says. The results are strong, demonstrating that neurons activity was altered by the touch of the spike of the virus through NRP1.

In an experiment in rats with a nerve injury to model chronic pain, administering the spike protein alone attenuated the animals pain behaviors. That finding hints that a spike-like drug that binds NRP1 might have potential as a new pain reliever. Such molecules are already in development for use in cancer.

In a more provocative and untested hypothesis, Khanna speculates that the spike protein might act at NRP1 to silence nociceptors in people, perhaps masking pain-related symptoms very early in an infection. The idea is that the protein could provide an anesthetic effect as SARS-CoV-2 begins to infect a person, which might allow the virus to spread more easily. I cannot exclude it, says Balistreri. Its not impossible. Viruses have an arsenal of tools to go unseen. This is the best thing they know: to silence our defenses.

It still remains to be determined whether a SARS-CoV-2 infection could produce analgesia in people. They used a high dose of a piece of the virus in a lab system and a rat, not a human, Balistreri says. The magnitude of the effects theyre seeing [may be due to] the large amount of viral protein they used. The question will be to see if the virus itself can [blunt pain] in people.

The experience of one patientRave Pretorius, a 49-year-old South African mansuggests that continuing this line of research is probably worthwhile. A motor accident in 2011 left Pretorius with several fractured vertebrae in his neck and extensive nerve damage. He says he lives with constant burning pain in his legs that wakes him up nightly at 3 or 4 A.M. It feels like somebody is continuously pouring hot water over my legs, Pretorius says. But that changed dramatically when he contracted COVID-19 in July at his job at a manufacturing company. I found it very strange: When I was sick with COVID, the pain was bearable. At some points, it felt like the pain was gone. I just couldnt believe it, he says. Pretorius was able to sleep through the night for the first time since his accident. I lived a better life when I was sick because the pain was gone, despite having fatigue and debilitating headaches, he says. Now that Pretorius has recovered from COVID, his neuropathic pain has returned.

For better or worse, COVID-19 seems to have effects on the nervous system. Whether they include infection of nerves is still unknown like so much about SARS-CoV-2. The bottom line is that while the virus apparently can, in principle, infect some neurons, it doesnt need to. It can cause plenty of havoc from the outside these cells.

Read more about the coronavirus outbreak from Scientific American here. And read coverage from our international network of magazines here.

Originally posted here:
What We Know So Far about How COVID Affects the Nervous System - Scientific American

Doctors contemplating plasma therapy to improve neurological condition of Soumitra Chatterjee – The Indian Express

By: PTI | Kolkata | Updated: October 25, 2020 9:08:54 amSoumitra Chatterjee is undergoing treatment at a private hospital in Kolkata for the past 18 days after he tested COVID-19 positive. (Photo: Express archive)

Doctors are contemplating whether plasma therapy can be useful to improve the neurological condition of legendary actor Soumitra Chatterjee who is undergoing treatment at a private hospital in the city for past 18 days after he tested COVID-19 positive.

Dr Arindam Kar, who is leading the team of doctors in treating the veteran actor said in a statement on Friday evening, that the other organ functions like liver, kidney and heart conditions of Chatterjee are okay but he is barely arousable.

As he has responded briefly for steroids our neurology panel is contemplating whether plasma therapy can be useful and we are mulling future plan of action, Kar said.

The doctor said since Chatterjee has been in ICU for three weeks, it is always challenging to prevent secondary complications.

The present neurological condition of the octogenarian was due to Covid encephalopathy extended for a while, he said. It will be huge effort to get him out of this situation with other therapies for neurological complications. We hope he should recover, Kar said.

Also Read | Soumitra Chatterjees health a cause of concern, says doctor

The doctors are also administering anti-convulsants and stimulants to get him up and to rule out any auto immune disorder, post covid, he said.

The critically acclaimed actor, who has worked with renowned filmmakers like Satyajit Ray, Mrinal Sen, Tapan Sinha and Tarun Mazumdar, was admitted to the hospital on October 6 after he tested COVID-19 positive.

The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Entertainment News, download Indian Express App.

Read this article:
Doctors contemplating plasma therapy to improve neurological condition of Soumitra Chatterjee - The Indian Express

The dementia that can be cured – The Guardian

When John Abraham began to lose his mind in late 2019, his family immediately feared the worst. Abraham had enjoyed robust health throughout retirement, but now at 80 he suddenly found himself struggling to finish sentences.

I would be talking to people, and all of a sudden the final word wouldnt come to mind, he remembers. I assumed this was simply a feature of ageing, and I was finding ways of getting around it.

But within weeks, further erratic behaviours started to develop. Abrahams family recall him often falling asleep mid-conversation, he would sometimes shout out bizarre comments in public, and during the night he would wake up every 15 minutes, sometimes hallucinating.

Patients can go from being in a nursing home, unable to communicate, to returning to work

To his son Steve, the diagnosis seemed inevitable, one which all families dread. I was convinced my dad had dementia, he says. What I couldnt believe was the speed at which it was all happening. It was like dementia on steroids.

Dementia is not just one disease it has more than 200 different subtypes. Over the past decade neurologists have become increasingly interested in one particular subtype, known as autoimmune dementia. In this condition, the symptoms of memory loss and confusion are the result of brain inflammation caused by rogue antibodies known as autoantibodies binding to the neuronal tissue, rather than an underlying neurodegenerative disease. Crucially this means that unlike almost all other forms of dementia, in some cases it can be cured, andspecialist neurologists have become increasingly adept at both spotting and treating it.

At the John Radcliffe hospital, University of Oxford, neurologist Sarosh Irani is one of the worlds leading experts in treating neurological conditions caused by a malfunctioning immune system. When Abraham was admitted under his care in early January 2020 following a seizure, Irani soon realised that the source of his problems was an autoantibody which targeted a protein in the brain named LGI1.

The main telltale clue was the speed of onset, one of the key distinguishing features of autoimmune dementia. The symptoms usually come on very quickly, Irani says. Over a few weeks or months, patients develop memory problems, and change their behaviour and personality. Patients with neurodegenerative forms of dementia can develop movement disorders or seizures, but this typically happens later in the illness once degeneration has set in. In autoimmune dementia, these are early problems.

Abraham underwent a treatment called plasma exchange, which aims to wash the blood of the disease-causing antibodies. The impact was almost instant. For me it caused a complete transformation, in one or two days, he says. My family came in to see me in the hospital, and they just looked at each other in amazement.

Such dramatic improvements are often reported as soon as treatment which can also include steroids and other immunotherapies begins. Patients can go from being in a nursing home, unable to communicate, to returning to work, being able to drive again, says Eoin Flanagan, a neurologist at the Mayo Clinic in Rochester, Minnesota, one of a handful of centres in the world along with Iranis research group, that is actively studying autoimmune dementia.

This is one reason why the condition, though rare Mayo Clinic neurologist Sean Pittock estimates that it makes up less than 5% of all dementia cases is so important to identify. The data available suggests that it is often missed. Among autoimmune dementia patients who were successfully treated at the Mayo Clinic between 2002 and 2009, 35% had been initially misdiagnosed with either Alzheimers or Creutzfeldt-Jakob disease.

A lot of patients over 60 are misdiagnosed, says Flanagan. Thats a concern because if you miss these cases, youre committing them to a presumed neurodegenerative course when they could respond to immunotherapy, and their symptoms resolve.

But autoimmune dementia is also an illustration of a broader trend. Over the past 15 years, treatable diseases have been identified across an entire spectrum of neurological illnesses from epilepsy to multiple sclerosis and psychiatry, all caused by autoantibodies binding to different parts of the brain and central nervous system.

Its become one of the most exciting areas of neurology, says Irani. There are subgroups within all these illness groups that have very treatable diseases. If youre a dementia doctor, a small percentage of your patients will have this condition, the same if youre a psychiatrist or a multiple sclerosis doctor. And with these patients you can actually directly treat the underlying cause by suppressing the immune system.

In October 2019, another patient was admitted to the John Radcliffe hospital.Pippa Carter, aged 19, had just begun an English literature degree at the University of Leeds when she noticed that her vision seemed to be strangely distorted.

I would be in lectures and I was really struggling to focus with my eyesight and with concentration in general, she says. I was trying to audition for a university play, and I had to stop because I couldnt really read at all. Initially, I thought it was just nerves because I was starting a new chapter in life.

Within weeks, she found herself unable to get her words out properly, before she was taken to hospital after suffering a large seizure. Just like Abraham, it was the speed of her decline which alerted doctors to a potential autoimmune cause. Within a week she was hallucinating, shouting things, remembers Irani. In her hospital room, which she was in for several weeks, she drew these bizarre childlike pictures on the wall, like the sorts of things a four-year-old would draw. It was like something was causing her to regress in her behaviour.

Carter was suffering from a neuropsychiatric syndrome caused by an autoantibody binding to the brains NMDA receptors, proteins which play a key role in learning and memory formation. Soon after she began treatment, first with steroids, and then an immunotherapy called rituximab, she began to improve. Now more than a year on, she is hoping to resume her university studies soon.

Since 2004, scientists have been steadily discovering the autoantibodies behind these various neurological conditions, making it possible for clinics to test for them. Irani says that so far they have discovered approximately 25, with one or two new autoantibodies detected every year. There are probably many more out there still, he says. Were not at the tip of the iceberg, but I think were probably nowhere near the base either.

Precisely what stimulates the body to produce these autoantibodies remains unclear, but it is thought that there can be a variety of environmental triggers ranging from viral infections to tumours, along with an underlying genetic susceptibility.

Due to the number of patients who can be successfully treated, specialists are looking to raise awareness of the importance of keeping an eye out for them. Its really a not-to-miss set of conditions, says Irani. Our clinic runs a diagnostics lab where we receive UK-wide samples for many of these diseases. One in 100 are positive, and these patients clearly get better with steroids and similar medications.

There are signs that the interest is growing. In November 2019, data was published from the first clinical trial looking at the effectiveness of different treatments for patients with a type of epilepsy caused by LGI1 autoantibodies. Two more trials are under way looking at new experimental therapies aimed at trying to stop the body from producing these damaging antibodies.

Irani is hoping that this will yield many benefits in years to come. Theres definitely an under-recognition of these conditions, he says. But as the field continues to expand, there will be more and more of these patients who get picked up. Im sure that if you look hard enough in acute psychiatry wards, and in nursing homes, there are patients out there with treatable conditions who are being missed.

Go here to read the rest:
The dementia that can be cured - The Guardian

I have the rare Alice in Wonderland syndrome, here’s what it’s like – Insider – INSIDER

It would always happen late at night.

I would be lying in bed and gently winding down into sleep. My eyes would begin to feel peculiar, as though they were being squeezed. Suddenly, I would notice that the room around me had begun to appear as if I were looking at it down the wrong end of a telescope.

My bedroom furniture, my posters and ornaments, and the walls looked tiny, as though they were dollhouse-sized. At the same time, I felt huge, like I could reach out and touch the ceiling with my fingertips.

Everything I could see had a warped, fish-eye quality to it. If I turned on my bedroom light, the room would suddenly switch back to normal, but the only other "cure" for this odd phenomenon was falling asleep.

This happened to me frequently when I was a kid, most often when I was especially tired, ill, or stressed. I didn't have the words to explain what was happening to me at night, I only knew that it felt unusual and dream-like but I knew that I wasn't dreaming.

When I told my parents that sometimes at night "everything looked small" they took me to an optician, where I discovered that I needed glasses and my prescription meant that I had a problem with depth perception.

Problem solved, I thought. But the episodes kept happening.

Sometimes everything around me would look dollhouse-sized. zef art/Shutterstock

I wasn't frightened by these episodes where everything around me looked like a reflection in a fun-house mirror. I loved fairy tales, and what I was experiencing didn't seem odd in the context of magic wands, evil stepmothers, and kids being able to talk to animals.

As I grew older, the episodes became more infrequent and, eventually, I forgot they had ever happened. But recently one night I was lying in bed, feeling tired and stressed, and I felt the same familiar tightening around my temples.

Suddenly, the room around me shrunk to dollhouse proportions.

Amazed, I stretched out my seemingly giant hand and felt as though I could easily touch the far-off wall opposite my bed.

Later that same week, I happened to discover a New York Times article that finally had an explanation, a name, and a diagnosis for what was happening to me I had Alice in Wonderland syndrome.

Discovered in 1955 by British psychiatrist John Todd, episodes of this rare curiosity, also known as Todd's syndrome, tend to involve macropsia (objects appearing larger than they are), teleopsia (objects appearing further away than they are), and micropsia (objects appearing smaller than they are).

Some people who experience this perceive their own body parts as being larger or smaller than in reality, and the whole episode can be accompanied by a sense of derealization (feeling like things around you aren't real) and depersonalization (feeling detached from your own body or mind).

It's sort of similar to what Alice experienced when she ate the mushroom in Lewis Carroll's famous book "Alice's Adventures in Wonderland" and altered the size of her body hence the name of the syndrome.

The syndrome has been linked to migraines, epilepsy, strokes, head trauma, infections, drugs, and stress but it's not known to be dangerous.

It's also not yet clear what causes the illusions and distortions, although it's not believed to be a hallucination or an eyesight problem.

Alice and the mushroom pieces in "Alice in Wonderland" (1951). Disney

Some who have studied this under-researched syndrome believe it's caused by changes in the portion of the brain that processes how we see our environment, possibly because of electrical activity which causes abnormal blood flow to that area.

Some doctors also believe it to be a type of migraine aura, which are sensory disturbances that can sometimes alter one's vision just before a migraine.

Dr. Grant Liu, a pediatric neuro-ophthalmologist at the Children's Hospital of Philadelphia, said he's seen a lot of patients with "odd complaints" over the years.

"Kids complain of seeing things that are too small, too large, too close, and too far away," he told Insider.

A few years ago, he conducted a study into Alice in Wonderland syndrome where he examined and spoke to 48 patients who experienced symptoms between 1993 and 2013.

He was able to link 33% of cases of the syndrome to exposure to infections (such as the flu), 6% to head trauma, and 6% to migraines. But in 52% of the cases, no cause was found.

His research also found that although the syndrome typically affects young children, it continued until later in life for about a third of patients he studied.

Miniature Alice and the Mad Hatter in "Alice in Wonderland" (2010). Walt Disney Studios

ButDr. Liu said he was most fascinated by the familial link he's seen with the syndrome, which makes him think that it could be more common than people think.

"For the study, we called families to follow up five to 15 years after diagnosing their children with Alice in Wonderland syndrome," he told Insider. "During those phone calls, lots of parents admitted that they too had experienced symptoms as children but when they were in the exam room, they were too embarrassed to admit it."

Although Dr. Liu said people experiencing Alice in Wonderland syndrome should see a specialist, as it can be a manifestation of a seizure or a migraine, he was quick to assure me that "there's no treatment necessary, it's really just reassurance."

People are less lonely when they embrace uncertainty and feel empathy, a study found

Disney once owned a town in Florida called Celebration, but the reality isn't very magical

How getting breast-reduction surgery helped me lose 50 pounds and changed my life

See the article here:
I have the rare Alice in Wonderland syndrome, here's what it's like - Insider - INSIDER

Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical &…

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Biomarkers Market.

Trusted Business Insights presents an updated and Latest Study on Biomarkers Market. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Biomarkers Market during the forecast period.It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2020-2026 (Includes COVID-19 Business Impact)

We have updated Biomarkers Market with respect to COVID-19 Business Impact.Inquire before buying

This report focuses on the Biomarkers market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Biomarkers market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.

Global Biomarkers Market: Segment Analysis

The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.

Global Biomarkers Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.

Global Biomarkers Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.List of Companies Profiled

F. Hoffmann-La Roche Ltd., Abbott, and Thermo Fisher Scientific, Inc. are Leading Market PlayersThe biomarkers market is a highly fragmented market. To strengthen their position, key market players are focusing on the introduction of novel biomarker tests, and entering in mergers and partnerships with other prominent companies with an aim to establish a strong brand presence. F. Hoffmann-La Roche Ltd., Abbott, and Thermo Fisher Scientific, Inc. dominated the biomarkers market share in 2018. Other players operating in the market are Bio-Rad Laboratories, Inc., Sino Biological Inc., BioVision Inc., Myriad RBM, R&D System, Axon Medchem, CENTOGENE N.V., and others.

List of key Companies Covered:

REPORT COVERAGE

The biomarker market report provides detailed information regarding various insights of the market. Some of them are growth drivers, restraints, competitive landscape, regional analysis, and challenges. It further offers an analytical depiction of the biomarkers market trends and estimations to illustrate the forthcoming investment pockets. The market is quantitatively analyzed from 2021 to 2026 to provide the financial competency of the market. The information gathered in the report has been taken from several primary and secondary sources.

Report Scope & Segmentation

By Indication

By End User

By Geography

INDUSTRY DEVELOPMENT:

May 2019: QIAGEN received FDA approval for therascreen RGQ PCR Kit. The therascreenPIK3CA Kit is the first companion diagnostic assay approved to identify breast cancer patients eligible for treatment with PIQRAY (alpelisib). PIQRAY (alpelisib), a newly approved therapy for breast cancer developed by Novartis AG.

May 2017: F. Hoffmann-La Roche Ltd., received the U.S. Food and Drug Administration (FDA) for biomarker assay for bladder cancer. This biomarker assay evaluates the status of patient PD-L1 by using both immune cell staining and tumor cell staining and scoring within the tumor.

 

Looking for more? Check out our repository for all available reports on Biomarkers Market in related sectors.

Quick Read Table of Contents of this Report @ Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2020-2026 (Includes COVID-19 Business Impact)

Trusted Business InsightsShelly ArnoldMedia & Marketing ExecutiveEmail Me For Any ClarificationsConnect on LinkedInClick to follow Trusted Business Insights LinkedIn for Market Data and Updates.US: +1 646 568 9797UK: +44 330 808 0580

Excerpt from:
Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical &...

Using Analytical Chemistry To Put an End to Corked Wine – Technology Networks

The sound when the cork pops out of the bottle is satisfying isnt it? But what disappointment if at that very first sip the look of pleasure and anticipation turns to disgust when the off flavors of a faulty wine hit your tongue thats if it even gets past your nose.

There are seven common faults that can be identified in wines, although a limited degree of some may be appreciated as pleasant by some consumers. These faults include oxidation (in excess), reduction, Brett (caused by Brettanomyces yeast), excess sulfur dioxide (SO2) (naturally produced during wine making and used to stabilize wines), volatile acidity, out of condition (over-age, bad storage) and last but by no means least 2,4,6-trichloroanisole (TCA), more commonly known as cork taint.

In the article we are going to focus on cork taint a fault not appreciated by anyone in the wine production, retail or consumer chain.

Cork is a natural product, stripped bark from the cork oak (Quercus suber). Consequently, as with any food or beverage product, good agricultural practice is necessary to minimize contamination by unwanted microbes during processing, transport and storage. Because of the nature of corks source, typical contaminants include soil-borne bacteria, yeasts and most commonly fungi. It is a subset of these fungi that are associated with cork taint. Species most frequently associated with cork taint include isolates from the genera Trichoderma and Fusarium, although other fungal species are also known to be involved.

To defend itself from fungal attackers, the tree produces phenolic compounds. In retaliation the fungi defend themselves by methylating the phenolic compounds which makes them less toxic, resulting in compounds such as anisole. When anisole then comes into contact with chlorine, which is frequently used as an antimicrobial during cork sterilization, it is converted to TCA et voila! If an affected cork is then used to stopper a bottle of wine, the compound is transferred into the wine as it comes into direct contact.

Cork taint is a harmless to health, naturally-occurring fault in bottles of wines closed by corks. It results in a very unattractive, moldy, wet cardboard smell that additionally reduces the fruit character of wine (it has nothing to do with pieces of cork breaking off and being seen in the bottle or glass). It can be detected by tasters at very low concentrations commented David Way, Wine Qualifications Developer at the Wine and Spirit Education Trust (WSET). Whilst the characteristics of cork taint have been described as a fault for decades, it wasnt until the 1980s that the compound responsible for taint was actually identified1, 2.

It has been estimated that 2-7% of wines suffer from cork taint3, 4; not only disappointing for the consumer but resulting in economic loss for producers and retailers. Thats aside from the sacrilege of potentially losing rare fine wines. However, these figures are reducing as the cork industry seek to address the issue.

A group of trained wine judges were put to the test and a geometric mean of the minimum detectable concentrations of TCA determined at 4.6 ng/L. Levels in the wines themselves below this should theoretically be undetectable to consumers and therefore offer a maximal threshold for acceptable limits of cork-to-wine transfer.

A host of laboratory-based analytical techniques can be applied to wines to determine if they contain TCA. Headspace solid phase microextraction (SPME) in combination with gas chromatography-mass spectrometry/ selective ion monitoring (GC/MS-SIM) has been shown to work well in detecting TCA in wines. SPME has also been used on wines and cork material to detect TCA at levels beyond olfactory detection. Headspace SPME and heart-cut multidimensional gas chromatography with tandem mass spectrometric detection has also proved effective. However, from a production point of view, every cork is an individual, so short of uncorking and testing every wine before it is sold, these techniques are not helpful in preventing cork taint in the first place.

In terms of whole, natural corks, the primary focus of efforts has been on identifying corks that contain TCA to prevent them reaching the bottling line.

A non-destructive technique called the dry-soak method was and is still used in some places to detect individual corks containing TCA. Here, every large format cork is held individually in a sealed glass jar containing 5-10 drops of de-mineralized water. Over 48 hours, the moist environment volatizes the TCA and then the corks are sniffed by a human expert panel. A study comparing this technique to chemical analysis by GC-MS found the dry-soak method effective in detecting tainted corks. However, this technique is labor intensive and due to sensory fatigue, only around 200 corks can be sniffed in one sitting, stopping for breaks every 50 corks. It may be effective, but this is therefore certainly not a method suited to a high throughput environment.

Given the sheer volume of corks used in the wine industry there is clearly a need for a quantitative, automated system for accurately detecting and rejecting affected corks.

A number of groups in both academia and industry, fostering collaboration between chemists and the cork industry, have successfully sought non-invasive, sensing device solutions that detect volatile organic compounds (VOCs), including TCA, on individual corks, rapidly.

A multi-center EU-funded project successfully developed an electronic nose, consisting of a sensor array, capable of detecting TCA down to 2 ng/L at a rate of 250 corks per hour. Whilst promising, the project has however not produced a solution available to producers. Whilst they can be useful technology, electronic noses lack the sensitivity required to detect TCA at the levels required and as such dont provide a solution for detecting affected corks currently commented Professor Ulrich Fischer, Head of the Institute for Viticulture and Oenology, Service Center for Rural Areas (DLR) Rheinpfalz, Germany.

A partnership was able to create a similar GC-based system with an analytical detection limit of a mere 0.5 ng/L, well below that detectable by a consumer. Each cork is checked individually with the cork sniffers currently able to test one cork every 16 seconds, each typically checking around 34,650 corks a week. But the goal is one every 10 seconds!

An alternative based on gas phase spectroscopy, also a result of industry-academia collaboration, analyzes corks one-by-one in an automated system and can be used on washed and unwashed corks. It too has a limit of detection of 0.5 ng/L and takes just 5 seconds to analyze each cork.

Seems like a huge waste of natural resources you may be thinking but fear not! Rejected corks can still find a useful life in applications such as flooring and gaskets.

An alternative approach is to prevent the formation of TCA in the first place by sterilizing and reconstituting the cork. The cork industry has responded with two main approaches cleaning cork with steam or creating closures with recomposed cork particles that have been cleaned and reconstituted with plastic. These responses are probably what has led to the reduction in corked bottles in recent years and give wine consumers the familiar ritual of opening a bottle with a corkscrew commented Way.

Corks fragments that have been sterilized with supercritical CO2 and glued back together have been a huge success in the wine industry. As the compounds used to reform them do not contain plasticizers they have been well received and accepted by many as a good and safe alternative to whole natural corks commented Fischer. He continued, Reconstitution also enables manufacturers to control the porosity of the corks to oxygen so they can be tailored to different types of wine. A red Bordeaux for example may benefit from a cork that enables greater oxygenation to develop its character, whilst a Riesling from Germany may benefit from less oxygenation to retai
n the floral aromatic character of the wine.

Recently, a Swiss group have developed a membrane that is able to filter TCA out of wines. Fischer continued, This is an exciting development for wine producers and suppliers. Whilst not economically viable for wines at the cheaper end of the market, it ensures rare and expensive wines are not lost and means suppliers are able to provide the vintages their customers want.

Plastic corks and screw cap closures have gained popularity in many parts of the world, particularly in New World wines. However, they are still fallible with compromised seals resulting in leakage and spoiled wines from excessive oxidation.

Synthetic closures avoid the hazards associated with TCA, but they lack the microporous properties of cork that allow minute quantities of oxygen into the bottle. Whilst excessive oxygenation is undesirable, small quantities of oxygen are a necessary part of the bottle ageing process that help to develop the tertiary characteristics of the wine think savory, meaty notes in a red, or honeyed, dried fruit in a white wine.

Therefore, whilst rubber corks and screw caps may be a good solution to protecting wines bottled for immediate consumption, they are not appropriate for premium wines that are designed to be bottle matured for a number of years.

Non-traditional corks are a very much contentious subject within the industry and the strength of opposition such that in some regions any closure except natural cork is banned under local wine production regulations.

The main approaches to dealing with cork taint have been either to use other types of closure, especially screw caps, or to ensure that corks do not contain TCA. Screw caps have been widely adopted in Australia and especially New Zealand (among many other countries) and have been accepted, especially for inexpensive and mid-priced wines in some markets, for example, the UK. There has been less take up by wine makers in Europe and less acceptance of alternative closures in some major market, such as France, Italy and the USA (although attitudes are changing in the last named) concluded Way.

Researchers have been developing new cork-free screw caps that incorporate a breathable liner, enabling micro dosing of oxygen into the bottle. It is still however early days and they have not been widely adopted so it is unlikely you will pick one up off the supermarket shelf anytime soon.

Aside from their physical and chemical properties, studies have shown that many consumers prefer natural corks and it impacts their perception of quality, an important consideration for wine producers and retailers wishing to get the best price for their wines.

Despite the potential shortcomings of natural cork. It is worth considering the green, biodegradable and renewable nature of cork over alternatives. Cork oaks grow for around 25 years before the first harvest, benefitting the environment and providing habitat. Once harvested a skillful job, the bark of the cork oak regrows too, and can be harvested every 8-14 years, offering long-term productivity.

References

1.Tanner H, Zanier C, Buser HR. 2,4,6-Trichloranisol: Eine dominierende komponente des korkgeschmacks, Schweiz. Z. Obst-Weinbau. 1981;117:97-103.

2.Buser H, Zanier C, Tanner H. Identification of 2,4,6-trichloroanisole as a potent compound causing cork taint, J. Agric. Food Chem. 1982;30:359-362.

3.Silva Pereira C, Figueiredo Marques JJ & San Romo MV. Cork taint in wine: Scientific knowledge and public perception A critical review. Critical Reviews in Microbiology. 2010;26(3):147-162. doi:10.1080/10408410008984174

4.Butzke CE, Evans TJ, Ebeler SE. Detection of cork taint in wine using automated solid-phase micro extraction in combination with GC/MS-SIM. Chemistry of Wine Flavor, 1998;15:208-216. doi:10.1021/bk-1998-0714.ch015

The rest is here:
Using Analytical Chemistry To Put an End to Corked Wine - Technology Networks

Chemistry professor had the right formula for how to live and die – South Bend Tribune

I wish that I had known Roger Schmitz, the former dean of the Notre Dame chemistry department and later a vice-president and associate provost at the university.

He loved to run and was still winning his age group into his 70s even though he laughingly admitted he sometimes didnt have any opponents.

He threw snowballs at his three girls, the three Js Jan, Joy and Joni even when they were adults and coached them in softball, sometimes having to nudge them off the bench for their two-inning minimum in the field. He loved giving them nicknames.

He enjoyed a wide variety of music from Bobby Darins Mack the Knife to the English folk song Greensleeves, from Roger Millers King of the Road to the Notre Dame Fight Song, of course.

He collected 200 autographs of major league ballplayers when he was growing up in Carlyle, Ill. His collection included 22 Hall of Famers with names like Musial, DiMaggio and Robinson.

He died of ALS (amyotrophic lateral sclerosis) in October of 2013 while the World Series played soothingly by his bedside.

During his 78 years, Roger Schmitz knew how to live and love and then leave this world in both a courageous and dignified way.

I dont think I ever met anyone who didnt enjoy being around my father, says Jan Schmitz Mathew, Rogers oldest daughter. And he demonstrated the same incredible grace and presence when he was dying that he had shown throughout his life.

To honor her dad, Jan has written a book, Surrounded by Love: My Familys Journey Through ALS. It is available at corbybooks.com, Amazon and the Hammes Notre Dame Book Store.

It is about Rogers life with his wife, Ruth, and their three daughters and the battle they faced together against Lou Gehrigs disease that took him in just seven months.

When his diagnosis was confirmed, he wrote his daughters. Everything else has been ruled out. Thats a bummer but it doesnt surprise me There will be bumps ahead, but we can handle them as you know.

Yes, they knew. Their dad had never been about self-pity or bitterness. He accepted what he couldnt change and moved on just as he had during an earlier bout with bladder cancer.

But in not much more than a years time, Roger went from still being able to jog around the block to needing a walker and then a motorized wheelchair and finally a scooter he bonded with.

And he kept his quirky sense of humor, Jan says.

When he once banged his scooter into a doorway, Jan remembers him saying, Well &$$%, Roger. Do you think you could clobber the wall just one more time today?

He never built walls around himself, though. He never tried to push his family away and go it alone.

Love is costly, the Rev. Paul Doyle wrote in the foreword of Jans book. And when we love, we carry crosses with each other. On the day Roger died, his last words to his daughters Jan, Joy and Joni were I love my Js. They and his wife Ruth had carried this cross with him.

Surrounded by Love is the story of that sad yet sometimes sweet journey of this uncommon man.

Heres another story about the late great Chicago Bear star and Wakarusa resident Gale Sayers from reader Michael Myers:

Its 1995 or so, and my son Matthew and I are walking down the midway at the Elkhart County Fair and I see Gale Sayers, Michael recalls. He was by himself, nobody bothering him, so I decided to change that. We approached him and I apologized for bothering him.

He was very friendly and I told him I wanted my son, who played football, to meet the greatest Bears running back ever. He then said as he was shaking Matthews hand, Is Walter Payton here?

You gotta love a humble man like that.

Congrats to the whole town of Buchanan for garnering the top honor on Reader Digests list of The Nicest Places in America.

Yeah, Ive always thought Buchanan was pretty cool. A couple of my friends come from there even though they probably should have been kicked out of town.

The Redbud City earned the accolades because of its 150-year-old tradition of honoring our fallen veterans on Memorial Day a summer march for racial justice with police chief Tim Ganus joining in Red Bud Area Ministries, which helps so many of the less fortunate the Scarecrow Factory and the Buchanan Promise scholarship fund to name a few reasons.

Life is better here, is Buchanans motto, and its citizens seem to believe that. Buchanan is a very supportive community, says 27-year-old Megan Goodrich, who sets up donation boxes for the homeless, according to the article. If you have an idea and want to do something, theres bound to be people here who will try to help you figure out how to make it happen.

Buchanan obviously is a happening place and now Readers Digests nicest of nicest places, too.

I was trying to out-drive my wife on Studebaker Golf Courses seventh hole when a ball plunked down on the No. 9 green and rolled into the hole not 30 yards from us.

Then Tribune sports editor Mike Wanbaugh came whooping down the hill like a banshee. Our buddy Kirby Sprouls had just made a double eagle/hole-in- one on the 265-yard hole.

In the last year, Ive been in the vicinity of two of my buddies making aces at Studebaker. If you pay my way ha, ha (it costs only $6 for a senior to walk), Ill serve as your lucky charm.

But then Kirby had to come clean: OK, before anyone calls Sports Illustrated because it was a heckuva shot, if I say so myself it was a mulligan. My first tee shot was a little left and a little short. With no one behind us, I decided to hit a second tee shot. The rest is history. But if I dont come clean on the mulligan, I would owe Wanbaugh drinks from Hammer & Quill for the rest of my life.

Sadly, Wanbaugh is like that ha, ha. But as groundskeeper Carl Spackler (Bill Murray) said in Caddyshack, Its in the hole!

Continued here:
Chemistry professor had the right formula for how to live and die - South Bend Tribune

Locker room chemistry is a key component the Steelers success in 2020 – Behind the Steel Curtain

The 2020 Pittsburgh Steelers have something special going on. Yes, they are 5-0 as they head to Nashville to take on the only other remaining undefeated team in the AFC. But there is something else to the Steelers team, and the more Steelers fans understand it the more they need to appreciate the Steelers front offices willingness to protect it.

The Steelers locker room is really something special.

Sometimes fans get it and sometimes they just dont see this aspect of the game. When a team comes together in the locker room, theres so much more they can do on the field. Of course its easier to have a good locker room when a team is winning, but this started long before the Steelers took the field for the first time in 2020.

Going through the different training camp setting required this season, the Steelers had a different mentality. From the beginning head coach Mike Tomlin made the statement of Its one fail, all fail which speaks both to the teams mentality when it comes to Covid procedures as well as the season in general. By players and personnel needing to take the precautions needed to in order to make this season happen, it appears it has brought this team together even more. Add the fact not one single Steelers player opted out for the season already and it felt like something special was going on with this team from the very beginning.

As the season progresses, more evidence continues to emerge about the quality the Steelers locker room. Ben Roethlisberger cannot say enough about his young wide receivers. Remember, Roethlisberger is only seven games removed from having a team which included Antonio Brown. Seeing the Steelers Pro Bowl wide receiver JuJu Smith-Schuster smiling and happy after a win where he had a minimal contribution shows the difference in this wide receivers room which Roethlisberger hasnt seen for a long time.

For those who may not have seen Thursdays Minkah Fitzpatrick interview, T.J. Watt and Bud Dupree decided to drop in and take over for a while. It was quite comical for anyone watching as Fitzpatrick burst out into laughter at their responses. While many may put this into just people having fun, the fact that they can have fun and not feel like theyre stealing each other spotlight is something to be noted.

Another example of the Steelers locker room being different is Steelers tight end Eric Ebron. One of the biggest complaints about Ebron coming into 2020 was his presence in the locker room in his previous stops in the NFL. What has happened since hes come to the Steelers? There havent been any problems reported. Additionally, Ebron is jumping for joy on the sidelines at Steelers games.

So whats the big deal? Why even talk about the Steelers locker room chemistry? Whether its great or if its terrible, does it really matter if the team is winning?

Yes, it does.

The biggest thing the Steelers need to make sure they do this season is not screw it up. As the trade deadline approaches, many feel the Steelers could possibly make a move to bolster their roster. But as much as a player can bring to the field, the Steelers also need to be aware of what the player would bring to the locker room.

I understand that just because someone has a black and gold T-shirt and a smart phone it doesnt mean they speak for Steelers Nation. There are plenty of takes presented on social media, many of which are absolutely terrible. Im going to highlight one or two that Ive seen from multiple places and show how little they consider locker room chemistry.

The Steelers need to trade JuJu NOW! Theyre going to get nothing from him if they dont.

Why are the Steelers concerned about getting something in return for a player who may or may not leave via free agency following this season? The Steelers are 5-0. This year is what its all about. Not only that, why would the Steelers even consider taking their locker room leader in the wide receivers room and shipping him off somewhere else? What message does that send to the other young players on the team? What if JuJu Smith-Schuster is the glue that holds them all together?

Im not going to quote the next one exactly, but even some former Steelers has chimed in on the topic of the Steelers trading for Dwayne Haskins. I dont understand the point. First, what are they going to have to give up to get him? Next, how is he going to help the Steelers win in 2020? And finally, why would the Steelers disrupt a quarterback room which appears to be functioning quite well?

In case youre wondering why I make the statement about a well-functioning quarterback room, its based on the James Washington touchdown in Week 6 against the Cleveland Browns. The story about this play is it was presented to Ben Roethlisberger on the sidelines by third-string quarterback Josh Dobbs who saw something where he thought it would work.

The reason this is such a big deal is Ben Roethlisberger is trusting the other players in the quarterback room. Why would Ben Roethlisberger listen to Dobbs unless these guys have something going on? Roethlisberger has been doing this more than all the other guys in the room combined, but yet Roethlisberger listened to Dobbs, Steelers scored a touchdown, and Roethlisberger gave Dobbs the credit.

How much do fans really know about the Steelers locker room? We can look for evidence through various things, but its really difficult to find out the information with certainty. After the fact, we found out so much about Steelers superstars from several years ago and the issues going on. But from everything that is coming out in 2020, this is not the case with this team. This team is rolling on and off the field.

As a Steelers fan, remember the importance of locker room chemistry, specifically in season. Yes, it would be nice if the Steelers could go out and compile as much talent as possible before the trade deadline. But if theres any question as to whether or not its going to upset the balance in the locker room while this team is on a roll, then dont even bother picking up the phone.

Read more:
Locker room chemistry is a key component the Steelers success in 2020 - Behind the Steel Curtain

Are Medicinal Chemists Taking It Too Easy? | In the Pipeline – Science Magazine

I was speaking to a university audience the other day (over Zoom, of course) and as I often do I mentioned the studies that have looked at what kinds of reactions medicinal chemists actually use. The clich is that we spend most of our time doing things like metal-catalyzed couplings and amide formation, and well, theres a reason that got to be such a clich, because theres a lot of truth in that.

At the same time, theres some evidence that innovative drug molecules come with innovative structures, more often than youd expect by chance. Its for sure that some of the hottest research areas right now (such as bifunctional protein degraders) can produce some rather off-the-beaten-track structures. So how do we reconcile these? Can we be making innovative drugs using a bunch of boring reactions?

This new paper (open access) says that yes, we sure can. The authors (from AstraZeneca) first note that about a third of all the reactions in AZs electronic notebooks are amide couplings, which sounds about right. They assembled two random sets of 10,000 compounds that had been made and screened in at least two assays, with one of them featuring amide formation and the other with it specifically excluded. These sets (Amide Formation and Other Reactions) were then evaluated by various techniques to roughly measure structural complexity, diversity, and novelty, and in addition the targets that they had hit in past AZ screens were examined.

And as it happens, the Amide Formation set had similar, but slightly higher complexity than the Other Reactions set. The two sets were virtually identical in lipophilicity and percent of saturated carbon atoms, but the amide group was slightly higher in molecular weight and the the number of chiral centers. As for molecular diversity, two different measurements broadly agreed: the Other Reactions set covered more diversity space, but the two sets also had significant non-overlapping regions. That is, the Amide Formation set was not just contained inside the larger diversity space carved out by the Other Reactions set, but had space all its own as well. And there was no real difference in novelty between the two sets, as measured by the number of structures that already occurred in databases such as ChEMBL. And when historical assay behavior was examined, the Amide Formation set had more active compounds in it, while the Other Reactions set covered a slightly wider range of assays themselves. But the two sets had a large overlap in the actual targets covered, so there was, in the end, not a significant difference between the two in target space.

The authors suggest that one reason that so simple a reaction as amide formation can hold its own (versus so many other possibilities) is that there are more and more unique amines available for such reactions. They looked through the ELNs for one-step amide couplings that made compounds for testing and examined the amines involved. On average, 8,000 different amines were used each year for such reactions, and every year about 2,000 of them were new. The authors:

In practice, building-block availability is one of the main determining factors. If the desired building blocks are unavailable, the chemist is faced with the decision whether to invest in new route development, or to make analogs with established routes, or to avoid making the target molecule at all. Given the uncertain nature of drug design, investing more time and resources in making a compound does not guarantee improved molecular quality.. .

. . .In medicinal chemistry, we have now reached a state where millions of building blocks have previously been engineered and can now be used in molecular design and synthesis. In addition to the increase in the number of new amines, boronic acids have been another fast-expanding reagent class since the introduction of the Suzuki coupling method

That really has been a change over my career. There are just so many more neat little functionalized compounds available now; its become an entire business of its own. As the paper notes, you even have setups such as Enamines REAL compound set, which is a virtual-but-easily-made collection via mixing and matching their available building blocks. That one would come out to well over a billion compounds if someone placed an order for the whole collection.

And if we can get our work done via such easy reactions plenty of experience in doing the reactions, relatively easy purifications, existing scaleup expertise, and so on then why shouldnt we? (I should note that the paper under discussion has a lot of good references to past arguments about this issue). That gets to another point I was emphasizing to my university audience: medicinal chemistry is a means to an end. The end, of course, is the discovery of useful drug molecules, and if the synthetic chemistry can (as much as possible) get out of the way of all the other tricky steps in that process, then so much the better.

Thats not to say that we shouldnt try new reactions or new technologies. Among other things, these can lead to even more new building blocks that can feed into the easy reactions themselves. And God knows, as you develop the SAR of a compound series you may find yourself unavoidably being pushed into difficult chemistry, where you will need all the help you can get and throwing amide couplings and Suzukis at the problem will avail you not. No, we definitely need our skills and our imaginations but we need them for the times we need them, and when we dont need them we should speed drug discovery along with the best tools we have for it. To paraphrase Einstein about physical theories, a synthetic route should be as simple as possible, but not any simpler. Getting as much done as you can with the easy methods leaves you more time to tackle the hard stuff. Get flashy only when you have to.

Go here to read the rest:
Are Medicinal Chemists Taking It Too Easy? | In the Pipeline - Science Magazine

Translating soil chemistry science to improve human health – Newswise

Newswise October 23, 2020 Contaminated soils with heavy metals or petrochemicals harm human health. And, children are 2-3 times more susceptible to the effects of contamination than adults.Translating Soil Chemistry Science to Improve Human Healthisa symposium to be held at theTranslating Visionary Science to PracticeASA, CSSA, SSSA International Annual Meeting. The virtual meeting will be hosted Nov. 9-13, 2020 by the American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America. Media are invited; preregistration is required.

The presentations are:

Presentations may be watched asynchronously, and there will be a scheduled Q&A time to speak with presenters during the meeting. Presentations will be available for online viewing for 90 days after the meeting for all registrants. For more information about theTranslating Visionary Science to Practice 2020meeting,visithttps://www.acsmeetings.org/.

Media are invited to attend the conference. Pre-registration by Nov. 2, 2020 is required. Visithttps://www.acsmeetings.org/mediafor registration information.

Read the original post:
Translating soil chemistry science to improve human health - Newswise

Plastic waste upcycled to high-value chemicals in one-pot process – Chemistry World

A one-pot method for converting polyethylenes into more valuable chemicals at low temperature has been demonstrated by researchers in the US. The early-stage research could potentially help tackle the Earths ever-growing mountain of waste plastic, and offers an alternative route to chemicals currently produced via energy-intensive processes that consume fossil fuels.

Plastics are a versatile class of materials with myriad applications, and today they are a ubiquitous and indispensable part of modern life. In 2015, global production of petroleum-based plastics was 380 million tonnes, and production is projected to double again within 20 years. However, their stability and chemical inertness also mean that they pose a significant waste problem because they can persist for hundreds of years when disposed of in landfill or in the environment. A 2017 study found that this was the fate of 79% of all plastic waste ever produced, with just 9% being recycled. Current industrial recycling methods typically involve simply washing the polymers before melting them down and reshaping them. However, these recycled plastics have inferior properties and lower value than virgin plastics. And while chemical recycling methods can, in principle, depolymerise some plastics to the monomer, this process is highly endothermic, posing a challenge for its economic viability.

Now, Susannah Scott of the University of California, Santa Barbara and colleagues have demonstrated the conversion of polyethylenes which represent 36% of all plastic waste to long chain alkylaromatic chemicals, which are more valuable than the original plastic. Alkylaromatics are currently produced mostly by reforming the crude oil fraction naphtha at 500600C to produce a mixture called BTX (benzene-toluene-xylenes), which is then alkylated in a next step that usesa strong acid catalyst, generating further environmental issues in separation and waste disposal. The teams new method involves direct conversion of polyethylenes to a mixture of linear alkylaromatics, using a platinum catalyst at a temperature of just 280C.

The group discovered its process by chance when attempting a different reaction. They were initially puzzled by their results because the low temperatures used shouldnt have been sufficient for aromatisation, which is highly endothermic. However, they realised that the hydrogen released by aromatisation was reacting with the polyethylene chains, promoting their breakdown into shorter chains. [Complete] depolymerisation would take polyethylene back to ethylene, and that reaction would be strongly endothermic, explains Scott. But were not going back to ethylene you can think about taking the large molecules and cleaving them with hydrogen to get alkanes, and thats an exothermic reaction. So coupling the reaction that produces the hydrogen with the reaction that consumes the hydrogen makes us nearly thermo-neutral.

The researchers demonstrated the process on a sample of low density polyethylene plastic bag and a high density polyethylene bottle cap, producing a range of linear alkylaromatics that could have uses ranging from surfactants and lubricants to refrigerants and insulating oils. They are working to develop a more scaleable, continuous process that can tolerate the mixed feed streams commonly found in real polymer waste. We have been working with mixtures and the process still works as long as the contaminants dont deactivate the catalyst, says Scott.

Its really exciting, says Charlotte Williams of the University of Oxford; Theyve identified a completely different product range [from cracking polyolefins] which definitely has a market and definitely have high value, and theyre able to make them with quite high selectivity in a reasonable temperature range. Its a long way from being a deployable system but they present really good data that gives people a frame of reference to understand whats going on and improve upon it.

In terms of the chemistry, being able to find that little window in the thermodymanics is not easy, says Yutan Getzler of Kenyon College in Ohio, I hope that they will do a follow up study in which the cost of getting realistic post-consumer material to a state in which their chemistry works would be seriously considered.

See original here:
Plastic waste upcycled to high-value chemicals in one-pot process - Chemistry World

Clippers address Doc Rivers departure, Ty Lues hiring and lack of chemistry – USA TODAY

SportsPulse: The Lakers and LeBron are back on top. LA gets their 17th. LeBron get his 4th. Both should look at this championship for what it is- arguably their most impressive feat yet. USA TODAY

The epic collapse called for some self reflection.

Less than two weeks after the Los Angeles Clippers squandered a 3-1 series lead to the Denver Nuggets in the Western Conference semifinals, Clippers owner Steve Ballmer did something he would have previously considered unthinkable.

Ballmer met with Doc Rivers, a man he considered a fantastic championship coach and a mentor. Ballmer then said he and Rivers concluded they should end a six-year partnership that yielded six playoff appearances without advancing past the second round.

It's very important to me that we not do anything in the heat of the moment, Ballmer said in a conference call Wednesday. That's not rational, like, 'Oh, we lost a game.'That's not sane. We took our time. Doc and I took our time together and arrived to the point we did.

After that, the Clippers had an exhaustive coaching search. They then simply hired from within by elevating assistant coach Tyronn Lue, whom Ballmer considered to be the best coach in the NBA four years after coaching the Cleveland Cavaliers to a league championship.

Ty Lue has learned from accomplished coaches (Doc Rivers, Gregg Popovich, Brad Stevens, Nick Nurse, Erik Spoelstra, Stan Van Gundy, Scott Skiles).(Photo: The Associated Press)

It's no secret we have had a difficult month, Clippers president of basketball operations Lawrence Frank said. We lost a series we were in position to win. We said goodbye to a coach we all greatly admire. We all take responsibility for what took place and have been working hard toward making the necessary improvements. The first step was finding the best head coach to lead us forward and grow with our group.

And with that, Lue has spent the past month pondering a question players have raised themselves. Why did a championship-contending team lack consistent chemistry?

We're talking about chemistry and continuity, and it's not more so off the court and guys not liking each other, Lue said. It was hard to get continuity and chemistry throughoutthe season because we didn't have a lot of practice time for our starting unit or our whole team for a large part of the season. When we talk about chemistry and continuity, it's more so on the basketball court of just being familiar with guys.

The Clippers spent the 2019-20 season missing a combined 114 games due to injuries and fielding 33 different starting lineups. That included Kawhi Leonard missing 13 games because of his left knee as well as Paul George sitting for 16 following surgery on both shoulders.

That did not stop the Clippers from finishing with the Western Conferences second-best record (49-23). But the Clippers experienced uneven performances during the season restart in the NBAs campus bubble partly because of their continued lack of continuity.

Lou Williams, the Clippers scoring specialist off the bench, spent 10 days in quarantine after veering from a pre-approved trip to his mentors funeral to stop at an Atlanta strip club for takeout food. Patrick Beverley, the defensive stalwart, missed four games. Montrezl Harrell, the NBAs 6th Man of the Year and adependable pick-and-roll scorer and defender, missed the season restart while spending time with his ailing grandmother.

Even when the Clippers finally fielded a full roster against Denver, they still struggled. George shot a combined 10-of-47 in Games 2-of-4 against Dallas in their first-round series, and attributed the slump toward mental health issues in the bubble. Despite rebounding with three more 30-point performances, George had only 10 points in a Game 7 loss to Denver. After staying consistent for most of the postseason, Leonard shot 6-of-22 in that same game.

I don't think we played our best basketball most of the time, frankly, we were in the bubble, Ballmer said. Certainly the way we ended our season, that really disappointed me.

Afterwards, the Clippers did not blame Rivers solely for that outcome.

We pride ourselves on being a tough, gritty, resilient team and for many different reasons, we weren't, Lawrence said. That's something we all have to look in the mirror; that we didn't respond to Denver's constant jabs to us; that we weren't able to be that tough, resilient group. So we have got to look deep within why that happened. But also give Denver credit. It's not as much as we lost as they took it, and you have to acknowledge that they were the better team for that series."

Still, the Clippers determined Lue as a better candidate both because of his familiarity with the roster and having a track record with a similar circumstance.

The Cavaliers fired head coach David Blatt midway through the 2015-16 season despite making the NBA Finals the previous season and starting off his second year with a 30-11 record. Lue then proved he could handle a group led by LeBron James, Kyrie Irving and Kevin Love that overcame a 3-1 series deficit to the Golden State Warriors in the NBA Finals.

Can Lue pull off a similar feat with the Clippers? No pressure, but his ability to do that might influence if Leonard and George stay since both can opt out of their contracts next summer.

I'm big on pressure because if you don't have pressure that doesn't mean you have a chance of winning the championship, Lue said. When you talk about pressure, that means you're in a situation to win. That's what I want to do. I want to be one of the greatest coaches.

Ballmer already sees Lue as one of those great coaches.

Lue learned from accomplished coaches (Rivers, Gregg Popovich, Brad Stevens, Nick Nurse, Erik Spoelstra, Stan Van Gundy, Scott Skiles). He played for the NBAs winningest coach (Phil Jackson). He played with a demanding superstar (Kobe Bryant). He coached a demanding superstar (James).

After the Cavs fired Lue following a 0-6 start in the 2018-19 season, he spent time bettering himself. He consulted his mentors, watched film and drew up plays. He improved his sleeping patterns and diet to lose 35 pounds.

Hes a thinker, he's a connecter, he's a dynamic leader who lifts you, even as he challenges you, Frank said of Lue. He's got the X's and O's. He's got the resume. He's also got the feel. It comes across in the way he sees the game from every angle and the way he relays his vision.

Still, Lue has some areas to address. Will Lue handle Leonards load management differently to ensure better chemistry?

It's something that I have to talk to with the medical staff and performance team, Lue said. I can't answer that question right now, but the most important thing is the health of our players.

Lue has already spoken to Leonard and George after his hiring. Once Lue finalizes hisstaff, how will he maximize what Leonard and George can offer on the court?

They have to adjust to my system and my program, but also have to be able to adjust to them, to their comfort zone and what makes them better, Lue said. It starts on the defensive end with those two guys of setting the tone every night.

Lastly, Lue conceded the team needs to play at faster at a better pace and improve its ball movement and spacing. But how will he handle a leadership vacuum that has entailed a stoic Leonard and George as well as a more outspoken bench unit in Williams, Beverley and Harrell?

You're not going to have the best players be the natural leaders at all times. It doesn't happen like that, Lue said. A lot of leadership has to come from me. I think it comes from Kawhi. I think it comes from PG and I think it comes from Lou and Pat Beverley. I don't think you can just say leadership isone person and put that demand on one person to do that. I think we have to do it as a committee.

Will that be enough for the Clippers to take the NBA championship trophy away from the Lakers? The team will find out within the next year whe
ther it can climb through its championship window.

I'm excited because the roster is unbelievable, Lue said. To have a chance and an opportunity to coach a team like the Clippers? I love their roster, I love the team, and I love what they stand for as an organization.

Follow USA TODAY NBA writer Mark Medina on Twitter, Facebook and Instagram.

Autoplay

Show Thumbnails

Show Captions

Visit link:
Clippers address Doc Rivers departure, Ty Lues hiring and lack of chemistry - USA TODAY

Study reports chemical mechanism that boosts enzyme observed in cancer – IU Newsroom

A new study led by scientists at IUPUI and Indiana University Bloomington is the first to describe a biochemical mechanism that increases the activity of a molecule whose presence is observed in many types of cancer.

The molecule, an enzyme called Pif1 helicase, plays a role in many important cellular processes in the body. Tightly regulating this protein is vital to genome stability because too little -- or too much -- activity can influence aging and age-related diseases, primarily cancer. A common cancer therapy, HDAC inhibitors, can also impact the mechanism that regulates this enzyme.

"We're currently giving people drugs that change the acetylation status of the cell without knowing how it affects many proteins that play a role in genome stability," said Lata Balakrishnan, an associate professor of biology in the School of Science at IUPUI, who is co-lead author on the study. "HDAC inhibitors upregulate certain tumor-suppression genes, and thus are used in combination therapies to treat specific cancers, but when it comes to their impact on other parts of the cell, we're basically operating in the dark."

The study's other lead author is Matthew Bochman, an associate professor in the IU Bloomington College of Arts and Sciences' Department of Molecular and Cellular Biochemistry. Other co-authors are Christopher Sausen and Onyekachi E. Ononye, Ph.D. students in Bochman's and Balakrishnan's labs, respectively, at the time of the study.

The effect of lysine acetylation on Pif1 is the mechanism described in the study. Lysine acetylation occurs when a small molecule called an acetyl group binds to lysine, an amino acid used to build common proteins in the body. This action transforms lysine from a positively charged molecule to a neutrally charged molecule. This neutralization can impact protein function, protein stability and protein-protein interaction in cells, among other things.

Helicases are known as the genetic "zippers" of cells because they pull apart DNA for the purpose of genetic replication and repair. They also help maintain telomeres, the structure at the end of chromosomes that shortens as people age.

In the new study, the researchers identified lysine acetylation on Pif1 helicase and showed the addition of the acetyl group increases the protein's activity -- as well as its "unzipping" function. They also found that lysine acetylation changes the shape -- or "conformation" -- of the Pif1 protein. They believe that this shape change increases the amount of Pif1 helicase.

"The dynamic interplay of the addition and removal of the acetyl group on lysine regulates a wide variety of proteins within the cell," Balakrishnan said. "Perturbations to this process can play a role in cancer, aging, inflammatory responses and even addiction-related behaviors."

"As a class, helicases are involved in a lot of processes necessary for genome integrity," Bochman added. "Any significant failure in these processes is generally carcinogenic."

The precise details of lysine acetylation in Pif1, its effect of the enzyme's shape and the resulting impact on helicase activity took nearly five years to observe and report. The study, carried out in parallel on two IU campuses, was made possible by the lead scientists' complementary expertise. As a biochemist who has previously studied lysine acetylation in other proteins, Balakrishnan was able to isolate Pif1 in vitro to observe its response to chemical reactions in a test tube. In contrast, as a geneticist working in yeast as a model organism to study Pif1, Bochman was able to modify cells in vivo to watch reactions play out in a living organism.

"The ability to observe these reactions in a living cell is often more relevant, but it's also a lot messier," Balakrishnan said. "Our experiments were constantly informing each other as to where to go next."

Looking to the future, Bochman said intricate knowledge of cellular processes -- such as lysine acetylation -- will increasingly play a role in personalized therapy.

"If you sequence a patient's tumor, you can fine-tune drugs to target very specific enzymes," he said. "Instead of a drug that broadly affects the whole cell, it will be possible to take a targeted approach that reduces potential side effects. This level of personalization is really the future of cancer biology and cancer medicine."

"Lysine Acetylation Regulates the Activity of Nuclear Pif1" is available online in advance of print in the Journal of Biological Chemistry. A perspective article on the work is also forthcoming in the journal Current Genetics.

This work was supported in part by the National Science Foundation, the National Institutes of Health and the American Cancer Society.

Indiana University's world-class researchers have driven innovation and creative initiatives that matter for 200 years. From curing testicular cancer to collaborating with NASA to search for life on Mars, IU has earned its reputation as a world-class research institution. Supported by $854 million last year from our partners, IU researchers are building collaborations and uncovering new solutions that improve lives in Indiana and around the globe.

View original post here:
Study reports chemical mechanism that boosts enzyme observed in cancer - IU Newsroom

Chemical Surface Treatment Market: Know about Impact of Covid-19 by Top Companies like PPG Industries, Inc. (US)., Nihon Parkerizing Co., Ltd.,…

The latest report published by Zeal Insider provides an in-depth analysis on the Chemical Surface Treatment Market with actual market values for the years 2018 and 2019 along with forecast for a period from 2020 to 2028. Thereby, the report provides historic market figures for the years 2018 and 2019 and offers an insight into the impact of COVID-19 on the Chemical Surface Treatment market for the forecast period from 2020 to 2028. The purpose of this study is to provide a detailed overview on the Chemical Surface Treatment market in pre-COVID-19 conditions and further provide information of how the market has changed since the onset of the pandemic.

Key players profiled in the report includes:PPG Industries, Inc. (US)., Nihon Parkerizing Co., Ltd., Platform Specialty Products Corporation, Atotech Deutschland GmbH, Henkel AG & Co. KGaA, NOF Corporation

Request for a Sample Report of Chemical Surface Treatment Market: https://www.zealinsider.com/report/2728/chemical-surface-treatment-market#sample

The investigative report provides a detailed analysis of the Chemical Surface Treatment market covering several aspects such as market dynamics, growth drivers, restraining factors, opportunities, challenges and recent developments in the market. The study has been collated based on exhaustive secondary research after studying numerous industry publications, government reports, company news and press releases. Further, these findings are backed by detailed primary research after interviewing numerous key opinion leaders, market participants, end-users and various other stakeholders in the Chemical Surface Treatment market.

The research report provides a detailed analysis on the Chemical Surface Treatment market segmented on the basis of type, application, end-use and geography. Thereby, the report aims to provide granular information on the performance of various product types based on its applications and end-use across key market countries across the world. The idea behind the report is to provide its audience with actionable insights on which market segments are more profitable currently and others which offer growth opportunities during the forecast period from 2020 to 2028.

The report provides a detailed competitive landscape including company profiles for leading market participants in the Chemical Surface Treatment market. Some of the details included in the company profile are product/service offering, financial information, business strategies and recent developments, among others. Furthermore, the report provides an in-depth company mapping based on their market share, revenues, growth and geographic presence. Thereby, the report includes a detailed analysis of various companies operating across the globe. Leading companies covered in the report include PPG Industries, Inc. (US)., Nihon Parkerizing Co., Ltd., Platform Specialty Products Corporation, Atotech Deutschland GmbH, Henkel AG & Co. KGaA, NOF Corporation, among others.

Place Inquiry for Buying or Customization of Report: https://www.zealinsider.com/report/2728/chemical-surface-treatment-market#inquiry

Chemical Surface Treatment Market Segmentation:

The report offers in-depth analysis of the Chemical Surface Treatment market based on various segments such as type, application and end-use industry. The Chemical Surface Treatment market is segmented as follows:

Chemical Surface Treatment Market, by Type:Metals, Plastics, Others

Chemical Surface Treatment Market, by Application:Transportation, Construction, General Industry, Industrial Machinery, Packaging, Others

Companies included in the Chemical Surface Treatment Market report:PPG Industries, Inc. (US)., Nihon Parkerizing Co., Ltd., Platform Specialty Products Corporation, Atotech Deutschland GmbH, Henkel AG & Co. KGaA, NOF Corporation

Geographic Coverage

The report on the Chemical Surface Treatment market provides a detailed country-level cross-sectional analysis across various regions around the globe. The report contains detailed market size and forecast for the following countries and regions:

North America Chemical Surface Treatment Market Revenue and Forecast

Europe Chemical Surface Treatment Market Revenue and Forecast

Asia Pacific Chemical Surface Treatment Market Revenue and Forecast

Latin America Chemical Surface Treatment Market Revenue and Forecast

Middle East and Africa Chemical Surface Treatment Market Revenue and Forecast

Access Full Report, here: https://www.zealinsider.com/report/2728/chemical-surface-treatment-market

This report provides an investigative analysis of the Chemical Surface Treatment market encapsulated in detailed sections such as

View post:
Chemical Surface Treatment Market: Know about Impact of Covid-19 by Top Companies like PPG Industries, Inc. (US)., Nihon Parkerizing Co., Ltd.,...

Ty Lue says Clippers’ chemistry issues were due to injuries and a resulting lack of continuity – CBS Sports

According to new Los Angeles Clipperscoach Ty Lue, the team's biggest issue this past season was chemistry, or a lack thereof. In Lue's eyes though, the chemistry wasn't an off-court issue, or the result of players not liking each other. Instead, Lue thinks that the lack of continuity caused by injuries is what prevented the Clippers from finding a real rhythm.

"I think when you talk about chemistry and continuity, it is not off the court, the guys not liking each other," Lue said in his virtual introductory press conference, via ESPN. "When you talk about chemistry, it is more so [Paul George] came in and he had shoulder surgery, so he was out, he missed the whole training camp and was out the first 11 games of the season. Kawhi [Leonard] came in and couldn't participate in the whole training camp, and then we lost Pat Beverley, in and out of the lineup a few times."

Moving forward, Lue is obviously hopeful that the Clippers will be able to develop more consistent chemistry, and a big part of that is leadership. As the two stars of the team, most automatically expect that Kawhi Leonard and Paul George will be L.A.'s de facto leaders. However, that won't necessarily be the case according to Lue, who thinks that leadership will be a collaborative effort between several of the squad's veteran players, as well as the head coach himself.

"Leadership is different," Lue said. "You can talk about our two players, Kawhi and PG, they lead by example... And you are not going to have the best players be the natural leaders at all times. It doesn't happen like that. I think a lot of leadership has to come from me, has to come from Kawhi, PG, Lou and Pat Beverley. It's going to be collective... I got to show them different ways of leadership and they got to show me different ways of leadership. I don't know everything. They don't know everything. ... The biggest thing about leadership is just communication."

Heading into his new gig facing championship expectations, Lue knows that there will be immense pressure on him and his players, but he thinks that all parties are prepared.

"Anytime you have a chance to win a championship, it's pressure," Lue said. "I want to be one of the greatest coaches. In order to be great, you have to win."

There will be some added pressure on the Clippers this season as Leonard and George both have the option to opt-out of their current contracts after the 2020-21 campaign, and if things don't go well again, that possibility could become a reality. Lue isn't worried about that though, as he's confident that the two stars will remain in Clippers uniforms for the foreseeable future.

"I think Kawhi, PG are here to stay for a long time. We just gotta make it a great environment and we have to win," Lue said. "... [Leonard and George] are going to have to adjust to my system and my program. But also I also have to be able to adjust to their comfort zone and what makes them better. Also setting the tone defensively of being the two best two-way players in the league. I think it starts on the defensive end with those two guys with setting a tone defensively. I think health is the biggest thing moving forward."

After leading LeBron James and the Cleveland Cavaliers to an NBA title in 2016, Lue certainly has experience when it comes to dealing with pressure-packed situations. That experience will serve him well in L.A., where he will be expected to hit the ground running. Next season, the Clippers will at least have to advance farther in the postseason than they did this year -- when they were defeated by the Dallas Mavericks in the Western Conference semifinals -- for Lue's first season to be considered successful.

More here:
Ty Lue says Clippers' chemistry issues were due to injuries and a resulting lack of continuity - CBS Sports

RPI researcher uses simple formula for chemical reactions to predict COVID-19 trajectory – Times Union

TROY A scientist at Rensselaer Polytechnic Institute has created a coronavirus transmission model inspired by one he uses to predict chemical reactions to help the Centers for Disease Control and Prevention forecast COVID-19 deaths across the country.

Developed by Yunfeng Shi, an associate professor of materials science and engineering at Rensselaer, and Jeff Ban, a professor of civil engineering at the University of Washington, the model uses fatality data collected by Johns Hopkins University and mobility data collected by Google to predict disease spread based on how much a population is moving within its community.

The researchers tested their model against data from 20 of the hardest hit counties in the United States and found it to be valid. Their findings are available in preprint on medRxiv, an online repository of papers that have been screened but not peer-reviewed.

The team has also been able to show how the forecasts change as schools open, communities lockdownand masks are mandated. The researchers website, which illustrates those forecasts, was developed by Tanooj Shah, a graduate student in Shis group.

Theres no mystery as to why theres an outbreak, Shi said. Theres no mystery to how we control it. The science is absolutely there. We want to use the model to give the local government some concrete predictive insight to implement certain policies.

Shi is a computational materials scientist who was curious about how simple chemical reaction analogs could be applied to forecasting COVID-19 transmission. Combined with Bans expertise in transportation and mobility, the two have developed a straightforward model that has been accurately predicting disease transmission.

They are now sharing their unique approach to forecasting COVID-19 spread with the CDC on a weekly basis, along with a collective of other research teams made up of infectious disease specialists, machine learning experts and modelers from across the nation. Combined, the models form an ensemble forecast from a multitude of perspectives.

The novelty of the model lies in the integration of physical modeling and data-driven approaches, which can bring useful insights about the infection and outbreak of COVID-19, Ban said. The findings of the research, such as the critical relative mobility indicator, can be used by policymakers for making informed decisions about when and how to reopen local economies.

The engineers plan to continue sharing their model results each week for the duration of the pandemic.

Pawel Keblinksi, the head of the Department of Materials Science and Engineering at Rensselaer, said the model is unique because of its simplicity and that it demonstrates that social mobility is a major contributing factor in controlling the spread of the virus.

"This is an example of the minimalist approach that Professor Shi used successfully to model complex physical reactive processes, including polymer or complex crystal growth," Keblinski said.

Continue reading here:
RPI researcher uses simple formula for chemical reactions to predict COVID-19 trajectory - Times Union

$5,000 Reward Offered In Chemical Attack That Left Germantown Grandmother Blind – CBS Philly

PHILADELPHIA (CBS) The Philadelphia Fraternal Order of Police Lodge 5 is offering a $5,000 reward for any information leading to the arrest of a suspect that attacked a Germantown grandmother earlier this month. Investigators say the suspect threw a mixture of dangerous chemicals in the womans face as she left her Germantown home on the 5100 block of Newhall Street.

The attack on Oct. 6 left 61-year-old Helen Jones with burns to her lips, tongue and eyes. Family members told Eyewitness News the potent mixture included Draino and it burned through Jones skin, leaving her blind.

Shes a phlebotomist, so she was leaving her home like she does every day. And he [the suspect] asked her, was she good, as if he was asking her about her safety, stepdaughter Aneesha Summerville said. When she looked up to him to respond to him to say yes, he threw a chemical in her face and ran off.

Police dont have a good description of the suspect. They say he was wearing a mask.

Summerville believes the suspect likely has a mental illness since the attack was random and unprovoked.

This random acid attack is a disturbing crime, FOP Lodge 5 President John McNesby said. We need to find this male suspect immediately to prevent another attack.

Anyone with information is being asked to call Northwest detectives at 215-686-3353, 9-1-1 or 686-TIPS.

Meanwhile, the family has created a GoFundMe to help with medical bills and the trauma therapy Jones will need.

MORE FROM CBS PHILLY:

Stimulus Package Update: What Happens To The Economy Without A Second Stimulus?

Pennsylvania Officials Confirm First COVID-19 Positive Cat In State

Bill Cosbys Latest Mugshot Trending On Social Media As He Appears To Be Smiling

See more here:
$5,000 Reward Offered In Chemical Attack That Left Germantown Grandmother Blind - CBS Philly

Two University of Chicago researchers elected to National Academy of Medicine – UChicago News

University of Chicago faculty members Melody Swartz and Holly J. Humphrey have been elected members of the National Academy of Medicineone of the highest honors in the field.

Swartz, the William B. Ogden Professor of Molecular Engineering at the Pritzker School of Molecular Engineering, was honored for pioneering contributions to the fields of lymphatic physiology, cancer research and immunotherapy. She holds a joint appointment in the Ben May Department for Cancer Research and is co-founder of the Chicago Immunoengineering Innovation Center.

Swartzs research focuses on gaining a deeper understanding of how the lymphatic system regulates immunity in homeostasis and disease, particularly in cancer and chronic inflammation. Her lab applies this knowledge to develop novel immunotherapeutic approaches to cancer, including lymph node-targeting vaccines. Her quantitative and interdisciplinary approach draws on bioengineering, immunobiology, physiology, cell biology and biomechanics.

Swartzs many honors include a MacArthur Fellowship (2012), as well as her election to the National Academy of Arts and Sciences (2018).

Humphrey, the Ralph W. Gerard Emeritus Professor in Medicine at the University, is currently president of the Josiah Macy Jr. Foundation. The academy honored Humphrey, MD83, for transforming medical education learning environments by creating cultures of equity, diversity, and belonging that prepare future health professionals to care for diverse populations and address social determinants of health.

Following an internal medicine residency, pulmonary and critical care fellowship, and chief residency at the University of Chicago, she served for 14 years as director of the Internal Medicine Residency Program. During her tenure as dean for medical education, her signature programs focused on equity, diversity and inclusion, mentoring, and professionalism.

She is also the chair of the Kaiser Permanente Bernard J. Tyson School of Medicines Board of Directors, chair emeritus of the American Board of Internal Medicine and of the American Board of Internal Medicine Foundation, and a past president of the Association of Program Directors in Internal Medicine.

Established originally as the Institute of Medicine in 1970 by the National Academy of Sciences, the National Academy of Medicine addresses critical issues in health, science, medicine, and related policy and inspires positive actions across sectors. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

Follow this link:
Two University of Chicago researchers elected to National Academy of Medicine - UChicago News

Clemson Continues to Lead on COVID-19 Testing, Expands Saliva-Based Capacity University received portion of $16.7 million commitment from State of…

Clemson Universitys robust testing strategy has been supplemented this week by additional capacity through saliva-based testing. In the three days of expanded saliva testing, the University has processed 1,599 tests, with 95% of results being returned the same day of the test.

The recent development of a laboratory certified by the Clinical Laboratory Improvement Amendments commonly called a CLIA Lab based in Jordan Hall on the main university campus has facilitated the increase in capacity. The University received a commitment of $6.9 million through Governor Henry McMaster and the States Joint Bond Review Committee to assist in the development and expansion of the CLIA Lab.

This funding provides the additional high capacity lab facilities, testing support and reporting resources to help Clemson University meet its obligations to its students, faculty and staff and further its Land Grant Mission of helping the State of South Carolina, Clemson University President Jim Clements said. Clemsons continued partnerships and collaborations with the other research universities across the state as well as its close working relationship with SC-DHEC will further the state and our communitys response to this pandemic.The goal of the CLIA labs is to 1) provide regular, rapid testing of Clemson faculty, staff, and students and 2) collaborate with DHEC to expand and facilitate rapid testing availability for the entire Upstate community and other institutions of higher education throughout the State.

Collaboration between Clemsons new CLIA labs and DHEC will help fight community spread through expanding availability of faster, less-invasive saliva-based tests to off-campus Clemson students, local school districts, and other members of the Upstate community.

Overseen by Delphine Dean, the Ron and Jane Lindsay Professor of Bioengineering, with the help of Mark Blenner, the McQueen Quattlebaum Associate Professor of Chemical Engineering, the lab employs 20 graduate students serving as the labs technicians. Approximately 30 undergraduates are helping with sample collection and are training in data handling and other tasks to assist the technicians.

When fully operational, the lab will be able to test 5,000 samples daily and return results the same day.

This is a multidisciplinary, University-wide effort to create a lab that is a cutting-edge solution to help fight COVID-19, Dean said. Were trying to ramp up quickly but safely.

Angie Leidinger, Clemsons vice president for External Affairs, said the lab is an example of the ingenuity that researchers are showing in the face of a global pandemic that is unprecedented in modern times.

Were grateful to Governor McMaster and the JBRC for this investment, Leidinger said. This funding not only assists in the immediate needs related to COVID, but also positions Clemson and the State of South Carolina to be a leader in competitive health-related research grants in the future.

Here is the original post:
Clemson Continues to Lead on COVID-19 Testing, Expands Saliva-Based Capacity University received portion of $16.7 million commitment from State of...